13F-HR filed by Ally Bridge Group (NY) LLC
Ally Bridge Group (NY) LLC filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 30 holding rows worth $116,635,007.
- Accession
- 0000950123-25-002405
- Filer
- CIK 1822947
- Filed
- 2025-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A holdings report, 30 entries on the cover page, a total value of $116,635,007 stated on the cover page (in dollars after the unit check, H1), rows summing to $116,635,007 with VALUE read as dollars as filed, 13F file number 028-20834. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFan Yu 028-20833
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 147,750 | $12,340,080 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 173,144 | $9,586,983 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 114,360 | $7,895,414 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 66,661 | $5,640,187 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 129,291 | $5,068,207 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 174,048 | $4,991,697 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 116,796 | $4,911,272 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 55,892 | $4,874,900 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 90,292 | $4,834,234 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 244,538 | $4,096,012 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 87,629 | $3,938,924 | dollars as filed | |
| GERON CORP | 374163103 | COM | 1,074,824 | $3,804,877 | dollars as filed | |
| ALUMIS INC | 022307102 | COM | 445,259 | $3,499,736 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 44,982 | $3,461,815 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 781,489 | $3,219,735 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 141,710 | $3,188,475 | dollars as filed | |
| KORRO BIO INC | 500946108 | COMMON STOCK | 70,678 | $2,690,711 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 122,424 | $2,617,425 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 348,000 | $2,592,600 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 817,939 | $2,580,598 | dollars as filed | |
| ATYR PHARMA INC | 002120202 | COM NEW | 699,730 | $2,533,023 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 317,833 | $2,485,454 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 175,063 | $2,433,376 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 106,434 | $2,320,261 | dollars as filed | |
| MIND MEDICINE MINDMED INC | 60255C885 | COM NEW | 330,275 | $2,298,714 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 83,176 | $2,220,799 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 54,692 | $1,976,022 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 1,576,762 | $1,655,600 | dollars as filed | |
| PROMIS NEUROSCIENCES INC | 74346M406 | COM NEW | 1,592,605 | $1,509,471 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 760,225 | $1,368,405 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-25-002405 | this filing | 2025-02-14 | acceptance time not in the bulk data set |